Tomoyuki Tano

594 total citations
28 papers, 479 citations indexed

About

Tomoyuki Tano is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Tomoyuki Tano has authored 28 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Tomoyuki Tano's work include Immune Response and Inflammation (14 papers), Immunotherapy and Immune Responses (7 papers) and Immune Cell Function and Interaction (4 papers). Tomoyuki Tano is often cited by papers focused on Immune Response and Inflammation (14 papers), Immunotherapy and Immune Responses (7 papers) and Immune Cell Function and Interaction (4 papers). Tomoyuki Tano collaborates with scholars based in Japan, China and India. Tomoyuki Tano's co-authors include Masato Okamoto, Mitsunobu Sato, Tetsuya Oshikawa, Motoo Saito, Yoichiro Moriya, Sharif Ahmed, Sachiko Furuichi, Yoshiki Ryoma, Shin Kan and Go Ohe and has published in prestigious journals such as PLoS ONE, Cancer Research and International Journal of Cancer.

In The Last Decade

Tomoyuki Tano

26 papers receiving 471 citations

Peers

Tomoyuki Tano
Tomoyuki Tano
Citations per year, relative to Tomoyuki Tano Tomoyuki Tano (= 1×) peers Yoshiki Ryoma

Countries citing papers authored by Tomoyuki Tano

Since Specialization
Citations

This map shows the geographic impact of Tomoyuki Tano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyuki Tano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyuki Tano more than expected).

Fields of papers citing papers by Tomoyuki Tano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoyuki Tano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyuki Tano. The network helps show where Tomoyuki Tano may publish in the future.

Co-authorship network of co-authors of Tomoyuki Tano

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoyuki Tano. A scholar is included among the top collaborators of Tomoyuki Tano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoyuki Tano. Tomoyuki Tano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tohyama, Mikiko, Masamoto Murakami, Tadashi Yoshida, et al.. (2018). Relationships between cetuximab‐induced anaphylaxis and specific antibodies against allergen and tick‐transmitted infections. Journal of Cutaneous Immunology and Allergy. 1(2). 58–63. 3 indexed citations
2.
Okamoto, Masato, Hiroyuki Goda, Tomoyuki Tano, et al.. (2014). Prognostic Significance of Interleukin-8 and CD163-Positive Cell-Infiltration in Tumor Tissues in Patients with Oral Squamous Cell Carcinoma. PLoS ONE. 9(12). e110378–e110378. 59 indexed citations
3.
Ishikawa, Akiko, Tomoki Sumida, Tomoyuki Tano, Ryuichi Murase, & Hiroyuki Hamakawa. (2014). A case of superficial angiomyxoma of the cheek region. Japanese Journal of Oral & Maxillofacial Surgery. 60(11). 609–613.
4.
Tano, Tomoyuki, Masato Okamoto, Shin Kan, et al.. (2013). Prognostic Impact of Expression of Bcl-2 and Bax Genes in Circulating Immune Cells Derived from Patients with Head and Neck Carcinoma. Neoplasia. 15(3). 305–IN35. 18 indexed citations
5.
Tano, Tomoyuki, Masato Okamoto, Shin Kan, et al.. (2013). Immunochemoradiotherapy for Patients with Oral Squamous Cell Carcinoma: Augmentation of OK-432-Induced Helper T Cell 1 Response by 5-FU and X-ray Irradiation. Neoplasia. 15(7). 805–814. 17 indexed citations
6.
Tano, Tomoyuki, Masato Okamoto, Shin Kan, et al.. (2012). Growth inhibition and apoptosis by an active component of OK-432, a streptococcal agent, via Toll-like receptor 4 in human head and neck cancer cell lines. Oral Oncology. 48(8). 678–685. 13 indexed citations
7.
Murase, Ryuichi, Tomoki Sumida, Akiko Ishikawa, et al.. (2012). The expression and roles of Id1 and Id2 in the aggressive phenotype of human oral squamous cell carcinoma cells. Journal of Oral and Maxillofacial Surgery Medicine and Pathology. 25(1). 12–17. 2 indexed citations
8.
Tano, Tomoyuki, et al.. (2007). A case of acinic cell carcinoma of papillary cystic type arising in the buccal mucosa. Japanese Journal of Oral & Maxillofacial Surgery. 53(4). 238–242. 2 indexed citations
9.
Oshikawa, Tetsuya, Masato Okamoto, Tomoyuki Tano, et al.. (2006). Antitumor Effect of OK-432–Derived DNA. Journal of Immunotherapy. 29(2). 143–150. 21 indexed citations
10.
Oshikawa, Tetsuya, Masato Okamoto, Sharif Ahmed, et al.. (2005). TX‐1877, a bifunctional hypoxic cell radiosensitizer, enhances anticancer host response: Immune cell migration and nitric oxide production. International Journal of Cancer. 116(4). 571–578. 8 indexed citations
11.
Okamoto, Masato, Tetsuya Oshikawa, Tomoyuki Tano, et al.. (2005). Mechanism of Anticancer Host Response Induced by OK-432, a Streptococcal Preparation, Mediated by Phagocytosis and Toll-Like Receptor 4 Signaling. Journal of Immunotherapy. 29(1). 78–86. 55 indexed citations
12.
Oshikawa, Tetsuya, Masato Okamoto, Tomoyuki Tano, et al.. (2005). Involvement of nitric oxide in anti-tumor effects of OK-432, a streptococcal anti-tumor immunotherapeutic agent. International Immunopharmacology. 6(5). 764–773. 5 indexed citations
13.
Okamoto, Masato, Sachiko Furuichi, Tomoyuki Tano, Hideo Yoshida, & Mitsunobu Sato. (2004). Intratumoral administration of dendritic cells in combination with TS-1, an oral fluoropyrimidine anti-cancer drug, and OK-432, a streptococcal agent. 53(1). 14–21. 2 indexed citations
14.
Ahmed, Sharif, Masato Okamoto, Tetsuya Oshikawa, et al.. (2004). Anti-Tumor Effect of an Intratumoral Administration of Dendritic Cells in Combination with TS-1, an Oral Fluoropyrimidine Anti-Cancer Drug, and OK-432, a Streptococcal Immunopotentiator. Journal of Immunotherapy. 27(6). 432–441. 30 indexed citations
16.
Okamoto, Masato, Go Ohe, Sachiko Furuichi, et al.. (2003). Enhancement of anti-tumor immunity by lipoteichoic acid-related molecule isolated from OK-432, a streptococcal agent, in athymic nude mice bearing human salivary adenocarcinoma: role of natural killer cells.. PubMed. 22(6A). 3229–39. 20 indexed citations
17.
Okamoto, Masato, Tetsuya Oshikawa, Go Ohe, et al.. (2001). Comparison of cytokine-inducing activity in a lipoteichoic acid-related molecule isolated from a penicillin-killed group A Streptococcus and from untreated bacteria. International Immunopharmacology. 1(11). 1957–1968. 16 indexed citations
18.
Oshikawa, Tetsuya, Go Ohe, Sachiko Furuichi, et al.. (2001). Severe impairment of anti-cancer effect of lipoteichoic acid-related molecule isolated from a penicillin-killed Streptococcus pyogenes in toll-like receptor 4-deficient mice. International Immunopharmacology. 1(9-10). 1789–1795. 36 indexed citations
19.
Ohe, Go, Masato Okamoto, Tetsuya Oshikawa, et al.. (2001). Th1-cytokine induction and anti-tumor effect of 55 kDa protein isolated from Aeginetia indica L., a parasitic plant. Cancer Immunology Immunotherapy. 50(5). 251–259. 10 indexed citations
20.
Okamoto, Masato, Go Ohe, Tetsuya Oshikawa, et al.. (2001). Enhancement of anti-cancer immunity by a lipoteichoic-acid-related molecule isolated from a penicillin-killed group A Streptococcus. Cancer Immunology Immunotherapy. 50(8). 408–416. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026